Positive list system corners pharmaceutical firms

Foreign and domestic pharmaceutical manufacturers are worrying about the current drug pricing system, the so-called positive list system, to allow only cost-effective drugs to be covered by national health insurance.

The Korean government introduced the positive list system in December 2006, under which only medicines with proven efficacy and price-competitiveness will be covered by health i...